Snyder Capital Management L P Emergent Bio Solutions Inc. Transaction History

Snyder Capital Management L P

$4.59 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$27.42 - $43.63 $5.6 Million - $8.91 Million	-204,300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $17.5 Million - $25 Million	-479,400 Reduced 70.12%	204,300 $8.39 Million
Q4 2021 Feb 14, 2022	SELL	$33.11 - $55.01 $5.3 Million - $8.8 Million	-160,054 Reduced 18.97%	683,700 $29.7 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $2.17 Million - $2.86 Million	43,331 Added 5.41%	843,754 $42.2 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $1.75 Million - $2.49 Million	30,991 Added 4.03%	800,423 $50.4 Million
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $3.96 Million - $5.75 Million	45,955 Added 6.35%	769,432 $71.5 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $4.66 Million - $6.56 Million	58,815 Added 8.85%	723,477 $64.8 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $18.5 Million - $30.5 Million	-226,034 Reduced 25.38%	664,662 $68.7 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $7.67 Million - $12.6 Million	-141,163 Reduced 13.68%	890,696 $70.4 Million
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $6 Million - $8.36 Million	-121,512 Reduced 10.54%	1,031,859 $59.7 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $1.48 Million - $1.71 Million	-28,992 Reduced 2.45%	1,153,371 $62.2 Million
Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $7.94 Million - $11.2 Million	195,635 Added 19.83%	1,182,363 $61.8 Million
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $1.41 Million - $1.9 Million	-35,291 Reduced 3.45%	986,728 $47.7 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $2.65 Million - $3.64 Million	55,029 Added 5.69%	1,022,019 $51.6 Million
Q4 2018 Feb 14, 2019	SELL	$55.63 - $73.24 $8.13 Million - $10.7 Million	-146,208 Reduced 13.13%	966,990 $57.3 Million
Q3 2018 Nov 14, 2018	SELL	$52.05 - $66.51 $1.02 Million - $1.31 Million	-19,624 Reduced 1.73%	1,113,198 $73.3 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $4.42 Million - $5.09 Million	-91,555 Reduced 7.48%	1,132,822 $57.2 Million
Q1 2018 May 14, 2018	SELL	$44.44 - $54.39 $806,319 - $986,852	-18,144 Reduced 1.46%	1,224,377 $64.5 Million
Q4 2017 Feb 13, 2018	BUY	$37.77 - $47.75 $5.45 Million - $6.89 Million	144,332 Added 13.14%	1,242,521 $57.7 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $37.5 Million - $44.4 Million	1,098,189	1,098,189 $44.4 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$34.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$30.2 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$22.2 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.8 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$17 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $443M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snyder Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Snyder Capital Management L P with notifications on news.

Account